Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease? - Wikidata - awgldk - TriplyDB

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

http://www.wikidata.org/entity/Q42055616

about

Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment.Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment.Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men.Cardiorenal metabolic syndrome and diabetic cognopathy.Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

P2860

Q31154291-64065959-BB6A-4C7D-B128-78B3AC163ABB Q36221514-DC5B1CDD-54ED-4C63-B7B9-36942D690755 Q36686081-5FA7980B-DCE3-49FC-87B4-62B185DE3CA4 Q37199221-5B9F76B9-AC19-4364-904A-E7A34C374EDD Q37344161-63232E46-A523-4C38-90C0-671F91E62EEA Q37514020-E7B83E77-A9CA-4F38-97B5-4F5538AB8636 Q38145620-33308A7F-2508-4F29-935B-F4A6CBDCA53B

P2860

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

http://www.wikidata.org/entity/Q42055616

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@en

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@nl

type

label

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@en

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@nl

prefLabel

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@en

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@nl

P1433

Q42055616-B588E15F-9A42-43C0-AD6E-CBEC3ADCB7F1

P1476

Q42055616-2AB6C707-F84B-4381-89E3-31384804FB43

P2093

Q42055616-377944E6-18F1-4090-8908-C8A1B5A6B83F

Q42055616-39E62887-E280-424B-AA44-70B91E0B6E8D

Q42055616-EE2CE696-84D2-499A-811C-CFAB9908CE65

Q42055616-EED0B100-4B2F-4EB8-BAFC-2318AC4FE396

P2860

Q42055616-02196EC6-B1BF-45B3-8FAA-A2082309973C

Q42055616-033BC077-4687-4A2F-88BA-5E0CE56C73B1

Q42055616-044DDC94-93A3-409F-B403-0AE60CBE20B3

Q42055616-05303673-F0AF-49D7-B9D1-8301C265F3C9

Q42055616-070AAFAC-D3B5-4ECB-85A7-357CE4EAC3D6

Q42055616-07C9E490-7114-43FC-92EF-08E07E60ACE3

Q42055616-0B3CF4A9-F028-4031-966C-1F4E52F82375

Q42055616-0D432834-10D5-4D54-96E1-7AAE982F387C

Q42055616-0FA31C66-171C-4C86-85F8-7ED096166DB6

Q42055616-1015261F-E069-4D99-BAE6-9353F9E9E377

P304

Q42055616-3AAB1E3D-667C-4205-A211-A21C691C117B

P31

Q42055616-3210CD6B-FEFC-4F94-9003-CDB7E82CA188

P356

Q42055616-EE4F7281-3E35-411E-BF92-4364176C1036

P478

Q42055616-00CFEF4B-5F76-4FFC-A16F-41139BA2BD85

P577

Q42055616-304D9599-55AE-4AF6-BE51-DC81F634BB03

P5875

Q42055616-11EC334D-69E2-45A2-9E30-17E50C872821

P698

Q42055616-361F42D4-61AA-4318-AF80-2BD0F6594821

P921

Q42055616-10811B66-CE2F-4A42-B79B-91C35229F30C

Q42055616-D2808894-4CA6-4121-87DD-1A670F9F0D76

P932

Q42055616-221AF29E-FC86-4DF0-B04F-F9B03C3C1CE3

P356

P1433

International journal of Alzheimer's disease

P1476

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

@en

P2093

Cassandra Andrade

http://www.w3.org/2001/XMLSchema#string

Douglas Walker

http://www.w3.org/2001/XMLSchema#string

Lih-Fen Lue

http://www.w3.org/2001/XMLSchema#string

Marwan Sabbagh

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

Calcium-regulated intramembrane proteolysis of the RAGE receptor

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Type 2 diabetes and cognitive impairment: linking mechanisms

Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells

Implication of Complement System and its Regulators in Alzheimer’s Disease

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

P304

918680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/918680

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229018202

http://www.w3.org/2001/XMLSchema#string

P698

22779027

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

type-2 diabetes

P932

3388453

http://www.w3.org/2001/XMLSchema#string